ASAlexander Ströhle

Alexander Ströhle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexander Ströhle has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 March 2016
      • Vol. 39  (3) , 123-8

    [The calcium debate--strong bones at the expense of cardiovascular health?].

    by Alexander Ströhle, Peyman Hadji, Andreas Hahn

    Ensuring an adequate intake of calcium--by means of supplements, if necessary--is a well-established approach in prevention and therapy of osteoporosis. However, in the meantime concerns have been voiced doubting the safety of calcium supplements. The discussion commenced when a new evaluation of the Auckland calcium intervention study revealed a higher rate of myocardial infarction after administration of calcium, compared to placebo. Two meta-analyses on the cardiovascular risk of calcium supplements supported these findings. Nevertheless, these results are still discussed contentiously. Doubts were increased by the fact that neither a reevaluation of the WHI calcium vitamin D study, nor a current meta-analysis could identify calcium as a cardiovascular risk factor. Against this background the present article analyses the controversial data with respect to the well-known "Hill-criteria" of causality, including consistency of data, magnitude of association, dose-response relationship and biological plausibility.

  • Die Bedeutung von Mikronähr stoffen für den Schlaf

    by Franziska Von Moeller, Thora Hartmann-Schneiders, Alexander Ströhle

    • 1 August 2015
      • Vol. 38  (8) , 297

    [Safety of folic acid].

    by Alexander Ströhle, Maike Wolters, Andreas Hahn

    Improving dietary folate intake is a central public health goal. However, critical voices have become louder warning of too high intake of folic acid. Safety concerns of a high folic acid exposure are usually limited to synthetic folic acid contained in drugs and food supplements. Against this background, the present article focuses on two matters: (a) How do the absorption and metabolism of synthetic folic acid differ from that of other folates? (b) How has the longterm safety of folic acid to be judged, especially regarding the risk of colorectal cancer, autism, asthma, impaired immune defence, masking vitamin B12 deficiency and interactions with the methotrexate metabolism?

    • 1 July 2014
      • Vol. 37  (7) , 249

    [Food supplements--possibilities and limitations: Part 6, Safety and possible risks].

    by Alexander Ströhle, Andreas Hahn

    Due to the precautionary principle in consumer protection, thresholds for long-term safety of nutrients have to be defined. Three toxical indicators are of interest: lowest observed adverse effect level (LOAEL); no observed adverse effect level (NOAEL) und tolerable level of upper intake (UL). An uptake of a nutrient within the range of UL is without side effects even on the basis of long-term consumption. The UL can be used to derive maximum levels for nutrients in food supplements. In general, vitamins can be regarded as safe nutrients except for vitamin A. Adverse effects only occur at excessive intake far beyond the recommended daily allowances. In contrast, the range of safe intake for minerals, especially trace elements, is much smaller. This can be seen clearly in the case of selenium. In order to prevent severe selenium deficiency a plasma concentration of > 0.25 micromol/l (> 20 microg/l) must be reached. To minimize cancer risk a plasma concentration of 1.5 micromol/l (120 microg/l) is needed. First signs of selenium intoxications occur at plasma levels over 250 microg/l. It is the dose that makes the preventive effect and the poison as well.

    • 1 January 2014
      • Vol. 37  (1) , 13-26

    [Food supplements in primary prevention--methodological aspects].

    by Alexander Ströhle, Andreas Hahn

    The terms "evidence" or "evidence-based medicine" (EBM) dominate the current biomedical debate. When asked about the usefulness of nutritional supplements, increasingly reliable studies and "evidence-based" recommendations are demanded. However, usually, it remains unclear what is meant by "evidence" and "evidence-based medicine". The aim of the current paper is to clarify and explain why continuous designed evaluation instruments, proofing the efficacy of pharmacological active compounds, cannot be applied without modifications to prove the benefits of nutrients. The focus bases on the following questions: (a) What does evidence-based medicine exactly means and how does it differ from non-evidence-based medicine? (b) What is the meaning of "evidence" and "evidence-based statements"? (c) What types of studies are suitable for securing evidence? (d) How can be drawn summarizing conclusions from various, sometimes divergent, results of single studies? (e) Which specific characteristics must be considered in the nutrition context?

    • 1 November 2013
      • Vol. 36  (11) , 422-6

    [Food supplements--potential and limits. Part 4: supplements in primary prevention--conceptual aspects].

    by Alexander Ströhle, Andreas Hahn

    Consumer's main cause for the use of food supplements is "disease prevention", but the benefit in prevention remains controversial. Furthermore, there are differing opinions concerning the doses of nutrients that should be applied. The conflict is due to two different sights of view on the effect of nutrients to health. The "classical" approach is on an endpoint: A deficit of a particular nutrient is associated with a specific deficiency syndrome. This means that the lack of a nutrient leads via a defined mechanism to one specific disease-related endpoint. Thus the adequate intake of nutrients is defined as the one in which no specific deficiency symptoms occur. In contrast, the modem approach is based on a multidimensional understanding of the nutrient-endpoint-relationship, taking into account long-term health effects. According to this extended approach, the adequate amount of nutrients is the one in which no specific, short-term deficiencies occur as well as the risk of chronic diseases is generally minimized. Usually, required nutrient intake to reach this exceeds the minimum requirements by several times.

    • 1 October 2013
      • Vol. 36  (10) , 369

    [Celiac disease--the chameleon among the food intolerances].

    by Alexander Ströhle, Maike Wolters, Andreas Hahn

    Celiac disease is an autoimmune disorder resulting from gluten intolerance and is based on a genetically predisposition. Symptoms occur upon exposure to prolamin from wheat, rye, barley and related grain. The pathogenesis of celiac disease has not yet been sufficiently elucidated but is being considered as an autoimmune process. At its core are the deamidation of prolamin fragments, the building of specific antibodies and the activation of cytotoxic T-cells. The immunological inflammatory process is accompanied by structural damages of the enterocytes (villous atrophy, colonization and crypt hyperplasia). The symptoms and their extent depend on the type of the celiac disease; classic and non-classic forms are being distinguished (atypical, oligosymptomatic, latent and silent celiac disease). Characteristics of the classic presentation are malabsorption syndrome and intestinal symptoms such as mushy diarrhea and abdominal distension. The diagnosis of celiac disease is based on four pillars: Anamnesis and clinical presentation, serological evidence of coeliac specific antibodies (IgA-t-TG; IgA-EmA), small intestine biopsy and improvement of symptoms after institution of a gluten-free diet. The basis of the therapy is a lifelong gluten-free diet, i. e. wheat, rye, barley, spelt, green-core, faro-wheat, kamuth and conventional oats as well as food items obtained therefrom. Small amounts of up to 50 mg gluten per day are usually tolerated by most patients; amounts of > or = 100 mg/day lead mostly to symptoms. Gluten-free foods contain < or = 20 ppm or 20 mg/kg (Sign: symbol of the 'crossed ear' or label 'gluten-free'). At the beginning of the therapy the fat and lactose intake may need to be reduced; also the supplementation of single micronutrients (fat-soluble vitamins, folic acid, B12, iron, and calcium) may be required. Alternative therapies are being developed but have not yet been clinically tested.


    • 1 September 2013
      • Vol. 36  (9) , 324

    [Food supplements--potential and limits: part 3].

    by Alexander Ströhle, Maike Wolters, Andreas Hahn

    Ageing processes are associated with physiological changes, e.g. a reduction of metabolically active body mass and an impaired hunger-satiety regulation, which--combined with chronic diseases and psychosocial problems--significantly increase the risk for malnutrition. However, considering their nutrition and health status elderly people are a very heterogeneous group. The nutrition situation of "young" seniors does generally not differ from the situation of working-age adults while institutionalized elderly people and those in need of care often show signs of a global malnutrition. The critical nutrients in the nutrition of the elderly particularly include vitamin B12 and D. Six percent of all elderly have a manifest and 10 to 30% a functional vitamin B12 deficiency. The main cause is vitamin B12 malabsorption resulting from a type B atrophic gastritis. The functional vitamin B12 deficiency and the associated hyperhomocysteinemia are risk factors for neurodegenerative diseases and accelerate bone loss. With increasing age the vitamin D status is deteriorating. About 50% of the elderly living in private households is deficient in vitamin D; in geriatrics vitamin D deficiency is more the rule than an exception. This is caused by a reduced endogenous biosynthesis, low UVB exposure and a diet low in vitamin D. A vitamin D deficiency increases the risk for falls and fractures as well as the risk for neurodegenerative diseases. Also the overall mortality is increased.


    • 1 July 2013
      • Vol. 36  (7) , 252

    [Nutrient supplements--possibilities and limitations: part 2].

    by Alexander Ströhle, Maike Wolters, Andreas Hahn

    Pregnant women are at greater risk of an insufficient vitamin and mineral supply. Based on hemodynamic, endocrine and metabolic changes due to pregnancy, the body weight and blood volume increase. These changes result in an increased requirement of most vitamins and minerals while the energy requirement increases by about 10%. Besides iodine (recommended intake as supplement 150 microg/d), iron (recommended intake 30-40 mg/d), vitamin D (recommended intake as supplement 20-50 microg/d), and docosahexaenoic acid (recommended intake 200 mg/d), folic acid is one of the critical micronutrients during pregnancy. Food folate and synthetic folic acid differ in their bioavailability. About 50% of the food folate is absorbed whereas almost 100% of folic acid from supplements is bioavailable. The contents are thus indicated as folate equivalents. In the form ofTHF, folic acid functions as coenzyme for the transfer of C1 units in the metabolism of amino acids, purines and pyrimidines. Folic acid (isolated or in combination with other vitamins and minerals) reduces the total risk for neural tube defects by 72%. For primary prevention it is recommended that all women who are planning to become pregnant take 400-800 microg synthetic folic acid along with a diet rich in folate. The additional intake should be continued at least until the end of the first trimester. For secondary prevention of neural tube defects an intake of 4 mg/d is recommended.


    • 1 May 2013
      • Vol. 36  (5) , 179-90

    [Nutrient supplements - possibilities and limitations].

    by Alexander Ströhle, Andreas Hahn

    The consumption of micronutrient-supplements by the general public has become widespread; between 25 and more than 40% of individuals questioned in western developed nations confirm to regularly consume such products. In principle, there are two product categories for micronutrient-supplements - medicinal products (drugs) and foodstuffs. The latter are marketed as food supplements (FS) and dietary foodstuffs for particular nutritional uses including foods for special medical purposes (FSMP). FS serve the general supplementation of any consumer whilst foodstuffs for particular nutritional uses are directed at consumers with special dietary requirements; FSMP are intended for the dietary management of patients. There are clearly defined legal frameworks for those product categories. Independently of their legal product status, six areas of application can be characterised for micronutrient-supplements: general and special supplementation, primary prevention, compensation of disease-related deficits, therapeutic function and containment of diseases or avoidance of subsequent damages (secondary and tertiary function). Gauged with the mean-intake, micro nutrient supply in Germany is sufficient (exception: folic acid and vitamin D; partially also iodine). However, the intake of vitamins E, C, B1 and B2 as well as the minerals calcium, magnesium, zinc and iodine could be improved in 20-50% of the general public. Micro nutrient preparations in physiological dose could contribute to closing this gap in supply.